Form D · Pharmaceuticals
Healthcare Corp of America
Denville, NJ · CIK 0001514682
Offering snapshot reported Jun 25, 2014 · SEC filing
- Reported sold
- $3.2M Offering amount: $3.2M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 2, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 25, 2014 | Initial | $3,200,000 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $220K
- Finders' fees
- $0
- Form D file number
- 021-219788
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Chardan Capital Markets | 120128 |
Source: Form D, filed Jun 25, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ruth Ackerman | Executive |
| Yoav Cohen | Executive |
| Yaron Eitan | Director |
| Natasha Giordano | Director, Executive |
| Edmundo Gonzalez | Director |
| Thomas Rebar | Director |
| Ann Saskowitz | Director, Executive |
| Scott Weeber | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
66 Ford Road Suite 230
Denville, NJ, 07834
Denville, NJ, 07834